| 6.04 Delayed Data As of Sep 20 |  -0.36 / -5.63%Today’s Change | 3.32 Today|||52-Week Range 9.38 | +47.32% Year-to-Date |
| Previous close | 6.40 |
| Today’s open | 6.40 |
| Day’s range | 6.02 - 6.48 |
| Volume | 4,257,307 |
| Average volume (3 months) | 1,328,839 |
| Market cap | $613.1M |
| Earnings growth (last year) | -20.36% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -0.25% |
| P/E ratio | NM |
| Price/Sales | 2,035.62 |
| Price/Book | 22.58 |
| Today’s change | Today’s % change | |
|---|---|---|
| RVNCRevance Therapeutics... | +0.31 | +2.20% |
| MGNXMacroGenics Inc | -0.13 | -1.00% |
| SVASinovac Biotech Ltd | 0.00 | 0.00% |
| QTRXQuanterix Corp | +0.44 | +1.85% |
| Next reporting date | November 6, 2019 |
| EPS forecast (this quarter) | -$0.35 |
| Annual revenue (last year) | $152.0K |
| Annual profit (last year) | -$173.5M |
| Net profit margin | -114,132.89% |
Sector Health Technology |
Industry Biotechnology |
Executive Chairman, President & CEO Michael Sean Weiss |
Chief Financial Officer, Secretary & Treasurer Sean A. Power |
Corporate headquarters New York, New York |
